Limited-stage Hodgkin lymphoma: Minimizing toxicity Journal Article

Author: Straus, D. J.
Article Title: Limited-stage Hodgkin lymphoma: Minimizing toxicity
Abstract: Early-stage classic Hodgkin lymphoma has been highly curable using extended-field radiation therapy (RT) alone, combined-modality therapy consisting of chemotherapy and RT, and more recently chemotherapy alone. Radiation therapy either to an extended field (extended-field RT) or to various iterations of an involved field (involved-field RT) is potentially associated with late morbidity and mortality, particularly second primary cancers and cardiovascular complications. Treatment with chemotherapy alone, when possible, can achieve a high cure rate while avoiding these risks. This review describes the evolution of treatment for early-stage classic Hodgkin lymphoma. © 2018 Wolters Kluwer Health, Inc. All rights reserved.
Keywords: chemotherapy; radiation; combined modality; long-term toxicity; early-stage classic hodgkin lymphoma
Journal Title: The Cancer Journal
Volume: 24
Issue: 5
ISSN: 1528-9117
Publisher: Lippincott Williams & Wilkins  
Date Published: 2018-09-01
Start Page: 223
End Page: 229
Language: English
DOI: 10.1097/ppo.0000000000000329
PROVIDER: scopus
PUBMED: 30247257
Notes: Review -- Export Date: 1 November 2018 -- Source: Scopus
Altmetric Score
MSK Authors
  1. David J Straus
    205 Straus